Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Change in Acquisitions & Divestments (2017 - 2025)

Editas Medicine (EDIT) has disclosed Change in Acquisitions & Divestments for 9 consecutive years, with $40.0 million as the latest value for Q3 2025.

  • Quarterly Change in Acquisitions & Divestments fell 53.96% to $40.0 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $170.5 million through Sep 2025, down 48.11% year-over-year, with the annual reading at $257.2 million for FY2024, 0.89% down from the prior year.
  • Change in Acquisitions & Divestments for Q3 2025 was $40.0 million at Editas Medicine, down from $42.5 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $130.8 million in Q1 2021, with the low at $31.5 million in Q4 2024.
  • Average Change in Acquisitions & Divestments over 5 years is $76.4 million, with a median of $74.2 million recorded in 2021.
  • The sharpest move saw Change in Acquisitions & Divestments soared 176.48% in 2021, then crashed 69.39% in 2024.
  • Over 5 years, Change in Acquisitions & Divestments stood at $84.3 million in 2021, then dropped by 6.91% to $78.5 million in 2022, then soared by 31.08% to $102.9 million in 2023, then plummeted by 69.39% to $31.5 million in 2024, then rose by 27.03% to $40.0 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $40.0 million, $42.5 million, and $56.5 million for Q3 2025, Q2 2025, and Q1 2025 respectively.